Zydenar to complete its new drug registration

Published: 2005-12-02 07:00:00

Updated: 2005-12-02 07:00:00

The KFDA has approved a new drug purely developed by a Korean pharmaceutical company called Zydena, an impotence drug, which will be the 10th new drug in Korea following "Factive" of LG Life Science. The KFDA announced on Nov. 29 that Zydenar 100mg and 200mg (udenafil).

The company describes Z...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK